ARCHIVES

Clinical Trials Approved Last Month By NCI’s CTEP

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

HEW Money Bills Mark Up Set May 26

May 20, 1977

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

Creating the Modern Cancer Center

November 2, 2021